Business4 hours ago
Cingulate Inc. Advances Toward ADHD Franchise with FDA Milestones
Cingulate Inc. (NASDAQ: CING) is making significant strides in its development of CTx-1301, a treatment aimed at addressing Attention Deficit Hyperactivity Disorder (ADHD). According to an...